-
, biomaterials, morphogenic factors and biophysical stimulation, explores 3D bioprinting and provides preclinical and clinical validation. It is located at the interface of cell therapy, smart biomaterials
-
scientific discoveries into tangible medical benefits for patients. This proposal articulates a comprehensive strategy aimed at attracting high-level research fellows, fostering robust international
-
details in https://umr-right.com ). Summary of the scientific project: The maintenance of T cell effector functions in vivo are critical for the success of cancer immunotherapies including Immune checkpoint
-
, Infibrex ; French Innovative Leukemia Organization, FILO and European Research Initiative on CLL, ERIC). In line with INSERM values, SIMHEL develops scientific projects to promote translational approaches